According to Perrigo's latest financial reports the company's total liabilities are $6.04 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $6.04 B | -2.17% |
2022-12-31 | $6.17 B | 17.09% |
2021-12-31 | $5.27 B | -9.59% |
2020-12-31 | $5.83 B | 6.11% |
2019-12-31 | $5.49 B | 3.42% |
2018-12-31 | $5.31 B | -2.62% |
2017-12-31 | $5.45 B | -31.02% |
2016-12-31 | $7.91 B | |
2015-06-30 | $8.89 B | 72.36% |
2014-06-30 | $5.15 B | 70.93% |
2013-06-30 | $3.01 B | 39% |
2012-06-30 | $2.17 B | 30.95% |
2011-06-30 | $1.65 B | -17.71% |
2010-06-30 | $2.01 B | 32.5% |
2009-06-30 | $1.52 B | -7.53% |
2008-06-30 | $1.64 B | 40.49% |
2007-06-30 | $1.17 B | 5.48% |
2006-06-30 | $1.10 B | -0.38% |
2005-06-30 | $1.11 B | 399.92% |
2004-06-30 | $0.22 B | 13.97% |
2003-06-30 | $0.19 B | 6.73% |
2002-06-30 | $0.18 B | -3.59% |
2001-06-30 | $0.19 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
United Therapeutics UTHR | $1.18 B | -80.43% | ๐บ๐ธ USA |
Endo International
ENDPQ | $11.73 B | 94.25% | ๐ฎ๐ช Ireland |
Intercept Pharmaceuticals
ICPT | $0.32 B | -94.68% | ๐บ๐ธ USA |
Catalent CTLT | $6.30 B | 4.30% | ๐บ๐ธ USA |